TCTR20220426001尚未招募不适用
The effect of Nintedanib in post-COVID-19 lung fibrosis: an observational study
Faculty of Medicine, Thammasat University0 个研究点目标入组 29 人开始时间: 2022年4月26日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 29
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 N/A (No limit)（—）
- 性别
- All
入选标准
- •1. Age 18 years or more, 2. Diagnosis of COVID-19 confirmed by RT-PCR test for SAR-CoV-2, 3. Diagnosis of pneumonia confirmed by chest imaging, 4. Hospital admission at Thammasat University Hospital, 5. Treatment with nintedanib or standard treatment
排除标准
- 未提供
研究者
相似试验
招募中
不适用
Effects of nintedanib in idiopathic pulmonary fibrosis - analysis on long term prognosis and predictive factorsIdiopathic pulmonary fibrosisJPRN-UMIN000021036ational Hospital Organization Tokyo Medical Center, Department of Respiratory Medicine100
招募中
3 期
Pirfenidone in Post COVID lung disease: Randomised controlled studyCTRI/2021/09/036442Sryma PB
Unknown
不适用
Incidence of post COVID-19 interstitial lung disease and impacts on lung function and quality of lifePost-COVID-19 interstitial lung diseasePost-COVID-19 ILDTCTR20220419013Routine to Research (R2R) Project, Faculty of Medicine Siriraj Hospital116
已完成
不适用
Anti-Inflammatory and Anti-Fibrotic Drugs in Post COVID-19 Pulmonary FibrosisPost-COVID-19 SyndromeLung FibrosisNCT05648734Mansoura University200
招募中
不适用
Intrapulmonal nintedanib distribution in fibrotic interstitial lung disease patients: drug concentrations in lung explantatesInterstitial lung diseaseNL-OMON21428Erasmus MC dept. of Medical Oncology and dept. of Pulmonology10